{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T09:08:25Z","timestamp":1715072905465},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1989,2,1]],"date-time":"1989-02-01T00:00:00Z","timestamp":602294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1989,2]]},"DOI":"10.1007\/bf00609184","type":"journal-article","created":{"date-parts":[[2006,8,17]],"date-time":"2006-08-17T17:32:32Z","timestamp":1155835952000},"page":"133-137","source":"Crossref","is-referenced-by-count":12,"title":["Effect of a long-acting somatostatin analogue (octreotide) on circulating tachykinins and the pentagastrin-induced carcinoid flush"],"prefix":"10.1007","volume":"36","author":[{"given":"H. J.","family":"Balks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Conlon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Creutzfeldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"St\u00f6ckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Suppl 5B","key":"BF00609184_CR1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0002-9343(87)90422-0","volume":"82","author":"W Creutzfeldt","year":"1987","unstructured":"Creutzfeldt W, St\u00f6ckmann F (1987) Carcinoids and carcinoid syndrome. Am J Med 82 [Suppl 5B]: 4\u201316","journal-title":"Am J Med"},{"key":"BF00609184_CR2","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1056\/NEJM197811092991908","volume":"299","author":"JC Fr\u00f6lich","year":"1978","unstructured":"Fr\u00f6lich JC, Bloomgarden ZT, Oates JA, McGuigan JE, Rabinowitwz D (1978) The carcinoid flush. Provocation by pentagastrin and inhibition by somatostatin. N Engl J Med 299: 1055\u20131957","journal-title":"N Engl J Med"},{"key":"BF00609184_CR3","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0024-3205(82)90087-X","volume":"31","author":"W Bauer","year":"1982","unstructured":"Bauer W, Briner U, Doepfner W, Haller R, Huguenin R, Marbach P, Petcher TJ, Pless J (1982) SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonge action. Life Sci 31: 1133\u20131141","journal-title":"Life Sci"},{"key":"BF00609184_CR4","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/S0140-6736(83)90847-4","volume":"2","author":"ME Kraenzlin","year":"1983","unstructured":"Kraenzlin ME, Ch'ng JC, Wood SM, Bloom SR (1983) Can inhibition of hormone secretion be associated with endocrine tumour shrinkage. Lancet 2: 1501","journal-title":"Lancet"},{"key":"BF00609184_CR5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM198501033120104","volume":"312","author":"PN Maton","year":"1985","unstructured":"Maton PN, O'Dorisio TM, Howe BA, McArthur KE, Howard JM, Cherner JA, Malarkey TB, Collen MJ, Gardner JD, Jensen RT (1985) Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera. N Engl J Med 312: 17\u201321","journal-title":"N Engl J Med"},{"issue":"Suppl 119","key":"BF00609184_CR6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/00365528609087453","volume":"21","author":"KD Buchanan","year":"1986","unstructured":"Buchanan KD, Shaw C, O'Hare MMT, Dalzell G (1986) Evaluation of SMS 201-995 in gastrointestinal APUDomas. Scand J Gastroenterol 21 [Suppl 119]: 199\u2013205","journal-title":"Scand J Gastroenterol"},{"key":"BF00609184_CR7","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/gut.26.5.438","volume":"26","author":"SM Wood","year":"1985","unstructured":"Wood SM, Kraenzlin ME, Adrian TE, Bloom SR (1985) Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue: Symptomatic and peptide responses. Gut 26: 438\u2013444","journal-title":"Gut"},{"issue":"Suppl 119","key":"BF00609184_CR8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/00365528609087459","volume":"21","author":"F St\u00f6ckmann","year":"1986","unstructured":"St\u00f6ckmann F, Richter G, Lembcke B, Conlon JM, Creutzfeldt W (1986) Long-term treatment of patients with endocrine gastrointestinal tumours with the somatostatin analogue SMS 201-995. Scand J Gastroenterol 21 [Suppl 119]: 230\u2013237","journal-title":"Scand J Gastroenterol"},{"issue":"Suppl 119","key":"BF00609184_CR9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/00365528609087457","volume":"21","author":"J Schrezenmeir","year":"1986","unstructured":"Schrezenmeir J, Plewe G, St\u00fcrmer W, Kahaly G, Oppermann D, Krause U, Del Pozo E, Kasper H, Beyer J (1986) Treatment of APUDomas with the long-acting somatostatin analogue SMS 201-995. Investigations of therapeutic use and digestive side-effects. Scand J Gastroenterol 21 [Suppl 119]: 223\u2013227","journal-title":"Scand J Gastroenterol"},{"key":"BF00609184_CR10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1056\/NEJM198707023170103","volume":"317","author":"RJ Comi","year":"1987","unstructured":"Comi RJ, Gesundheit N, Murry L, Gordon P, Weintraub RD (1987) Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue. N Engl J Med 317: 12\u201317","journal-title":"N Engl J Med"},{"key":"BF00609184_CR11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0140-6736(84)90320-9","volume":"2","author":"K Werder Von","year":"1984","unstructured":"Von Werder K, Losa M, M\u00fcller OA, Schweiberer L, Fahlbusch R, Del Pozo E (1984) Treatment of metastasising GRF-producing tumour with a long-acting somatostatin analogue. Lancet 2: 282\u2013283","journal-title":"Lancet"},{"key":"BF00609184_CR12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM198609113151102","volume":"315","author":"LK Kvols","year":"1986","unstructured":"Kvols LK, Moertel CG, O'Connell MJ, Shutt AJ, Rubin J, Hahn RG (1986) Treatment of the malignant carcinoid syndrome. N Engl J Med 315: 663\u2013666","journal-title":"N Engl J Med"},{"issue":"Suppl 119","key":"BF00609184_CR13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/00365528609087452","volume":"21","author":"G Richter","year":"1986","unstructured":"Richter G, St\u00f6ckmann F, Lembcke B, Conlon JM, Creutzfeldt W (1986) Short-term administration of the somatostatin analogue SMS 201-995 in patients with carcinoid tumours. Scand J Gastroenterol 21 [Suppl 119]: 193\u2013198","journal-title":"Scand J Gastroenterol"},{"key":"BF00609184_CR14","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/1097-0142(1984)54:4<715::AID-CNCR2820540420>3.0.CO;2-6","volume":"54","author":"PC Emson","year":"1984","unstructured":"Emson PC, Gilbert RFT, Martensson H, Nobin A (1984) Elevated concentrations of substance P and 5-HT in plasma in patients with carcinoid tumors. Cancer 54: 715\u2013718","journal-title":"Cancer"},{"key":"BF00609184_CR15","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1210\/jcem-63-3-605","volume":"63","author":"I Norheim","year":"1986","unstructured":"Norheim I, Theodorsson-Norheim E, Brodin E, \u00d6berg K (1986) Tachykinins in carcinoid tumors. Their use as tumor marker and possible role in the carcinoid flush. J Clin Endocrinol Metab 63: 605\u2013612","journal-title":"J Clin Endocrinol Metab"},{"key":"BF00609184_CR16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/00365528708991864","volume":"22","author":"JM Conlon","year":"1987","unstructured":"Conlon JM, Deacon CF, Richter G, St\u00f6ckmann F, Creutzfeldt W (1987) Circulating tachykinins (substance P, neurokinin A, neuropeptide K) and the carcinoid flush. Scand J Gastroenterol 22: 97\u2013105","journal-title":"Scand J Gastroenterol"},{"key":"BF00609184_CR17","first-page":"597","volume":"31","author":"S Falkmer","year":"1984","unstructured":"Falkmer S, Martensson H, Nobin A, Sundler F (1984) Peptide hormones in various types of gastro-entero-pancreatic tumors: immunohistochemical patterns and evolutionary background. Prog Cancer Res Ther 31: 597\u2013610","journal-title":"Prog Cancer Res Ther"},{"key":"BF00609184_CR18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1677\/joe.0.1110433","volume":"111","author":"E Pozo Del","year":"1986","unstructured":"Del Pozo E, Neufeld M, Schl\u00fcter K, Tortosa F, Clarenbach P, Bieder E, Wendel L, N\u00fcesch E, Marbach P, Cramer H, Kerp L (1986) Endocrine profile of a long-acting somatostatin derivative SMS 201-995. Study in normal volunteers following subcutaneous administration. Acta Endocrinol 111: 433\u2013439","journal-title":"Acta Endocrinol"},{"key":"BF00609184_CR19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0167-0115(83)90105-2","volume":"7","author":"JM Conlon","year":"1983","unstructured":"Conlon JM, Sheehan L (1983) Conversion of substance P to C-terminal fragments in human plasma. Regul Pept 7: 335\u2013345","journal-title":"Regul Pept"},{"key":"BF00609184_CR20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0197-0186(87)90085-4","volume":"10","author":"CF Deacon","year":"1987","unstructured":"Deacon CF, Conlon JM (1987) Biosynthesis of tachykinins (substance P, neurokinin A and neuropeptide K) in neurons of the guinea pig myenteric plexus. Neurochem Int 10: 559\u2013564","journal-title":"Neurochem Int"},{"key":"BF00609184_CR21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0167-0115(86)90225-9","volume":"13","author":"JM Conlon","year":"1986","unstructured":"Conlon JM, Deacon CF, Richter G, Schmidt WE, St\u00f6ckmann F, Creutzfeld W (1986) Measurement and partial characterization of the multiple forms of neurokinin A-like immunoreactivity in carcinoid tumours. Regul Pept 13: 183\u2013186","journal-title":"Regul Pept"},{"key":"BF00609184_CR22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/BF02012573","volume":"41","author":"ME Kraenzlin","year":"1985","unstructured":"Kraenzlin ME, Wood SM, Neufeld M, Adrian TE, Bloom SR (1985) Effect of long acting somatostatin-analogue SMS 201-995 on gut hormone secretion in normal subjects. Experientia 41: 739\u2013740","journal-title":"Experientia"},{"key":"BF00609184_CR23","first-page":"183","volume":"33","author":"C-R Martling","year":"1987","unstructured":"Martling C-R, Theodorsson-Norheim E, Norheim I, Lundberg JM (1987) Bronchoconstrictor and hypotensive effects in relation to pharmacokinetics of tachykinins in the guinea pig \u2014 evidence for extraneuronal cleavage of neuropeptide K to neurokinin A. Naunyn Schmidebergs Arch Pharmacol 33: 183\u2013189","journal-title":"Naunyn Schmidebergs Arch Pharmacol"},{"key":"BF00609184_CR24","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/00365528609015169","volume":"21","author":"OB Schaffalitzky de Muckadell","year":"1986","unstructured":"Schaffalitzky de Muckadell OB, Aggestrup S, Stentoft P (1986) Flushing and plasma substance P concentrations during infusions of synthetic substance P in normal man. Scand J Gastroenterol 21: 498\u2013502","journal-title":"Scand J Gastroenterol"},{"key":"BF00609184_CR25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2265.1988.tb00256.x","volume":"28","author":"HJ Balks","year":"1988","unstructured":"Balks HJ, Conlon JM, Creutzfeldt W, St\u00f6ckmann F (1988) Circulating bradykinin-like immunoreactivity and the pentagastrin-induced carcinoid flush. Clin Endocrinol 28: 141\u2013151","journal-title":"Clin Endocrinol"},{"key":"BF00609184_CR26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(64)92907-1","volume":"2","author":"JA Oates","year":"1964","unstructured":"Oates JA, Melmon K, Sjoerdsma A, Gillespie L, Mason DT (1964) Release of a kinin peptide in the carcinoid syndrome. Lancet 2: 514\u2013517","journal-title":"Lancet"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00609184.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00609184\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00609184","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T23:24:35Z","timestamp":1554420275000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00609184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1989,2]]}},"alternative-id":["BF00609184"],"URL":"https:\/\/doi.org\/10.1007\/bf00609184","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,2]]}}}